Venmax Drugs And Pharmaceuticals Ltd. announced unaudited standalone earnings results for the first quarter ended June 30, 2017. For the quarter, the company reported net loss for the period before tax, exceptional items and/or extraordinary items was INR 0.168 million compared with INR 0.1 million for the same period a year ago. Net loss for the period before tax and after exceptional items and/or extraordinary items was INR 0.168 million compared with INR 0.1 million for the same period a year ago. Net loss for the period after tax and after exceptional items and/or extraordinary items was INR 0.168 million compared with INR 0.1 million for the same period a year ago. Basic and diluted LPS was INR 0.03 against INR 0.02 a year ago.